Stocks · NYSE · Healthcare · United States

BMY — Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co. (BMY) is a healthcare stock listed on NYSE (United States). At the close of September 29, 2026 it traded at 62.86 (-1.60% on the day), -5.9% over one month, +12.6% over three months, +49.2% over twelve months. The InvestMuse composite score is +43 on a −100 to +100 scale, a bullish read that ranks #162 of about 1,221 assets. The strongest of its nine dimensions are Chart patterns and zones (+60) and Fundamentals (+59); the weakest is Trend (-18). Its volatility regime from the hidden Markov model is Calm. 136 news articles in the last 30 days carried an average tone of +0.11 (on −1 to +1).

Open the interactive read →Race BMY with $100k play money

The facts

Last close62.86 (September 29, 2026)
1 day / 1 month / 3 months / 12 months-1.60% / -5.9% / +12.6% / +49.2%
52-week range41.21 – 68.09
Composite score+43 / 100 · bullish view · rank #162
Volatility regime (HMM)Calm
Support levels37.00, 44.00
Resistance levels50.00, 56.00, 64.00
Trailing P/E12.7
Market cap$118.0B

The nine dimensions

Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.

How this read is made

Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.

Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.